相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Late Afternoon Dosing of Plerixafor for Stem Cell Mobilization: A Practical Solution
Dennis L. Cooper et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2011)
Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program
Nina Worel et al.
TRANSFUSION (2011)
Plerixafor given before the third leukapheresis to rescue an unsuccessful stem cell mobilization with CY and G-CSF
S. Nimmagadda et al.
BONE MARROW TRANSPLANTATION (2010)
Successful Stem Cell Remobilization Using Plerixafor (Mozobil) Plus Granulocyte Colony-Stimulating Factor in Patients with Non-Hodgkin Lymphoma: Results from the Plerixafor NHL Phase 3 Study Rescue Protocol
Ivana N. Micallef et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience
C. J. Fowler et al.
BONE MARROW TRANSPLANTATION (2009)
Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma
John F. DiPersio et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction
Steven M. Devine et al.
BLOOD (2008)
Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist
WC Liles et al.
TRANSFUSION (2005)
The role of diagnosis in patients failing peripheral blood progenitor cell mobilization
M Koenigsmann et al.
TRANSFUSION (2004)
Rapid mobilization of CD34+cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma
SM Devine et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Single versus double autologous stem-cell transplantation for multiple myeloma
M Attal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)